Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride usp is indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride usp is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride tablets are indicated for the prevention of: - nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. - nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride tablets are contraindicated in patients with known hypersensitivity to the drug or any of its components. manufactured in israel by: teva pharmaceutical ind. ltd. jerusalem, 9777402, israel manufactured for: teva pharmaceuticals usa, inc. north wales, pa 19454 rev. f 2/2016

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

west-ward pharmaceuticals corp. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride tablets are indicated for the prevention of: granisetron hydrochloride is contraindicated in patients with known hypersensitivity to the drug or any of its components.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

breckenridge pharmaceutical, inc. - granisetron hydrochloride (unii: 318f6l70j8) (granisetron - unii:wzg3j2mcol) - granisetron 1 mg - granisetron hydrochloride tablets usp are indicated for the prevention of: nausea and vomiting associated with initial and repeat courses of emetogenic cancer therapy, including high-dose cisplatin. nausea and vomiting associated with radiation, including total body irradiation and fractionated abdominal radiation. granisetron hydrochloride tablets are contraindicated in patients with known hypersensitivity to the drug or any of its components.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - granisetron hydrochloride, quantity: 1.12 mg/ml (equivalent: granisetron, qty 1 mg/ml) - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections; sodium hydroxide; citric acid monohydrate; sodium chloride - prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy in adults and children. prevention of nausea and vomiting induced by radiotherapy in adults only. prevention and treatment of post-operative nausea and vomiting in adults only.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - granisetron hydrochloride, quantity: 1.12 mg/ml (equivalent: granisetron, qty 1 mg/ml) - injection, concentrated - excipient ingredients: hydrochloric acid; sodium chloride; sodium hydroxide; citric acid monohydrate; water for injections - prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy in adults and children. prevention of nausea and vomiting induced by radiotherapy in adults only. prevention and treatment of post-operative nausea and vomiting in adults only.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - granisetron hydrochloride, quantity: 3.36 mg (equivalent: granisetron, qty 3 mg) - injection, concentrated - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; citric acid monohydrate; sodium hydroxide - adults: granisetron sandoz injection is indicated for use in adults for: - the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy; - the prevention of nausea and vomiting induced by radiotherapy. children: granisetron sandoz injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - granisetron hydrochloride, quantity: 1.12 mg (equivalent: granisetron, qty 1 mg) - injection, solution - excipient ingredients: sodium chloride; citric acid monohydrate; sodium hydroxide; hydrochloric acid; water for injections - adults: granisetron sandoz injection is indicated for use in adults for: - the prevention and treatment of nausea and vomiting induced by cytotoxic chemotherapy; - the prevention of nausea and vomiting induced by radiotherapy. children: granisetron sandoz injection is indicated for the prevention of nausea and vomiting induced by cytotoxic chemotherapy.

Канада - Енглески - Health Canada

omega laboratories limited - granisetron (granisetron hydrochloride) - liquid - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists

Канада - Енглески - Health Canada

strides pharma canada inc - granisetron (granisetron hydrochloride) - solution - 1mg - granisetron (granisetron hydrochloride) 1mg - 5-ht3 receptor antagonists